This company listing is no longer active
TBH Stock Overview
Designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. More details
Snowflake Score | |
---|---|
Valuation | 5/6 |
Future Growth | 2/6 |
Past Performance | 2/6 |
Financial Health | 5/6 |
Dividends | 0/6 |
Community vs My Fair Value
Select a narrative for quick price alerts from the community, or create your own.
Teleflex Incorporated Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$246.00 |
52 Week High | US$320.00 |
52 Week Low | US$232.00 |
Beta | 1.09 |
1 Month Change | 0% |
3 Month Change | 0% |
1 Year Change | -18.54% |
3 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | 557.05% |
Recent News & Updates
Recent updates
Shareholder Returns
TBH | DE Medical Equipment | DE Market | |
---|---|---|---|
7D | 0% | 1.2% | 1.7% |
1Y | -18.5% | -11.5% | 16.5% |
Return vs Industry: TBH underperformed the German Medical Equipment industry which returned -2.7% over the past year.
Return vs Market: TBH underperformed the German Market which returned 4.7% over the past year.
Price Volatility
TBH volatility | |
---|---|
TBH Average Weekly Movement | n/a |
Medical Equipment Industry Average Movement | 6.5% |
Market Average Movement | 6.5% |
10% most volatile stocks in DE Market | 12.9% |
10% least volatile stocks in DE Market | 3.1% |
Stable Share Price: TBH has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine TBH's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1943 | 14,000 | Liam Kelly | www.teleflex.com |
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. The company also offers interventional products, which consists of various coronary catheters, structural heart therapies, and peripheral intervention and cardiac assist products that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded catheters, Guideline and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices.
Teleflex Incorporated Fundamentals Summary
TBH fundamental statistics | |
---|---|
Market cap | €9.71b |
Earnings (TTM) | €396.85m |
Revenue (TTM) | €2.69b |
Is TBH overvalued?
See Fair Value and valuation analysisEarnings & Revenue
TBH income statement (TTM) | |
---|---|
Revenue | US$2.79b |
Cost of Revenue | US$1.27b |
Gross Profit | US$1.53b |
Other Expenses | US$1.12b |
Earnings | US$412.27m |
Last Reported Earnings
Sep 25, 2022
Next Earnings Date
n/a
Earnings per share (EPS) | 8.79 |
Gross Margin | 54.67% |
Net Profit Margin | 14.75% |
Debt/Equity Ratio | 43.8% |
How did TBH perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2022/11/16 01:44 |
End of Day Share Price | 2022/08/19 00:00 |
Earnings | 2022/09/25 |
Annual Earnings | 2021/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Teleflex Incorporated is covered by 35 analysts. 15 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Ishan Majumdar | Baptista Research |
Matthew Taylor | Barclays |
Craig Bijou | BofA Global Research |